Gapping down
In reaction to disappointing earnings/guidance: QGEN -11.8%, VRTX -4.6%, GCO -4%, EXAS -3%
Select China related names showing weakness with the Shanghai down over 5% last night: JD -2.2%, JMEI -1.7%, JKS -1.5%, CSIQ -0.9%, VIPS -0.9%, SFUN -0.9%, YY -0.7%, CTRP -0.6%
Other news: ACI -64% (files Chapter 11 bankruptcy, agrees on terms of debt restructure deal with Senior lenders), ASTI -12.9% (files 48 mln share common stock offering by a selling stockholder), NURO -5.6% (files ~16.505 mln share common stock offering issuable upon conversion of outstanding shares of Series C Preferred Stock & upon exercise of certain outstanding warrants by selling securityholders), BCLI -2.9% (enters into collaborative agreement with Hadassah Medical Center in Jerusalem), CYTK -1.9% (presents analyses demonstrating predictive value of slow vital capacity for clinical outcomes in ALS)
Analyst comments: UA -4.3% (downgraded to Underweight from Equal-Weight at Morgan Stanley), VFC -2.3% (downgraded to Underweight from Equal-Weight at Morgan Stanley), MJN -1.8% (downgraded to Neutral from Overweight at JP Morgan), WETF -1.4% (downgraded to Sell from Neutral at Goldman), JPM -0.5% (downgraded to Neutral from Buy at Goldman
)
In reaction to disappointing earnings/guidance: QGEN -11.8%, VRTX -4.6%, GCO -4%, EXAS -3%
Select China related names showing weakness with the Shanghai down over 5% last night: JD -2.2%, JMEI -1.7%, JKS -1.5%, CSIQ -0.9%, VIPS -0.9%, SFUN -0.9%, YY -0.7%, CTRP -0.6%
Other news: ACI -64% (files Chapter 11 bankruptcy, agrees on terms of debt restructure deal with Senior lenders), ASTI -12.9% (files 48 mln share common stock offering by a selling stockholder), NURO -5.6% (files ~16.505 mln share common stock offering issuable upon conversion of outstanding shares of Series C Preferred Stock & upon exercise of certain outstanding warrants by selling securityholders), BCLI -2.9% (enters into collaborative agreement with Hadassah Medical Center in Jerusalem), CYTK -1.9% (presents analyses demonstrating predictive value of slow vital capacity for clinical outcomes in ALS)
Analyst comments: UA -4.3% (downgraded to Underweight from Equal-Weight at Morgan Stanley), VFC -2.3% (downgraded to Underweight from Equal-Weight at Morgan Stanley), MJN -1.8% (downgraded to Neutral from Overweight at JP Morgan), WETF -1.4% (downgraded to Sell from Neutral at Goldman), JPM -0.5% (downgraded to Neutral from Buy at Goldman
)